K. Schoenfeld

Performance of an automated anti-SARS-CoV-2 immunoassay in prepandemic cohorts

P. Findeisen, C. Niederhauser, M. Laimighofer, 2020, medRxiv.

Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody

H. Kolmar, B. Hock, S. Carrara, 2023, Frontiers in Immunology.

Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1

Julia Harwardt, K. Schoenfeld, Harald Kolmar, 2024, Antibodies.

Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting

Julia Harwardt, Adrian Elter, Jan Habermann, 2023, Frontiers in immunology.

Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies

Julia Harwardt, P. Oberoi, Jordi Pfeifer Serrahima, 2024, Frontiers in immunology.

Better safe than sorry: dual targeting antibodies for cancer immunotherapy

Julia Harwardt, K. Schoenfeld, Harald Kolmar, 2024, Biological chemistry.